APVO · Aptevo Therapeutics Inc.
$2.94
-0.46 (-13.53%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“When considered in aggregate, these factors raise substantial doubt about our ability to continue as a going concern for the one-year period from the date of issuance of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.30M
Shares
1.80M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 11,995 | 581,240 | 593,235 | 41.7% |
| 2026-06-29 | 4,161 | 101,775 | 105,936 | 59.2% |
| 2026-06-22 | 1,324 | 28,666 | 29,990 | 57.7% |
| 2026-06-15 | 2,576 | 24,716 | 27,292 | 45.0% |
| 2026-06-08 | 3,874 | 39,275 | 43,149 | 57.2% |
| 2026-06-01 | 45,223 | 162,578 | 207,801 | 64.1% |
| 2026-05-25 | 8,871 | 112,266 | 121,137 | 62.3% |
| 2026-05-18 | 4,687 | 38,049 | 42,736 | 52.0% |
| 2026-05-11 | 7,280 | 43,023 | 50,303 | 52.1% |
| 2026-05-04 | 13,300 | 277,082 | 290,382 | 49.9% |
| 2026-04-27 | 1,725 | 36,751 | 38,476 | 69.7% |
| 2026-04-20 | 11,247 | 59,352 | 70,599 | 71.7% |
| 2026-04-13 | 10,987 | 75,075 | 86,062 | 57.8% |
| 2026-04-06 | 9,381 | 51,314 | 60,695 | 54.9% |
| 2026-03-30 | 13,590 | 210,455 | 224,045 | 64.3% |
| 2026-03-23 | 15,011 | 89,723 | 104,734 | 51.3% |
| 2026-03-16 | 16,564 | 66,778 | 83,342 | 50.1% |
| 2026-03-09 | 36,331 | 449,536 | 485,867 | 40.8% |
| 2026-03-02 | 7,895 | 61,257 | 69,152 | 68.6% |
| 2026-02-23 | 10,605 | 38,492 | 49,097 | 48.2% |
| 2026-02-16 | 8,559 | 47,146 | 55,705 | 51.1% |
| 2026-02-09 | 13,212 | 48,698 | 61,910 | 46.2% |
| 2026-02-02 | 28,949 | 171,598 | 200,547 | 54.4% |
| 2026-01-26 | 24,302 | 163,130 | 187,432 | 54.4% |
| 2026-01-19 | 29,782 | 133,892 | 163,674 | 52.4% |
| 2026-01-12 | 35,632 | 231,728 | 267,360 | 53.5% |
| 2026-01-05 | 130,121 | 2,487,549 | 2,617,670 | 38.9% |
| 2025-12-29 | 175,512 | 1,537,637 | 1,713,149 | 100.0% |
| 2025-12-22 | 557,495 | 10,728,512 | 11,286,007 | 100.0% |
| 2025-12-15 | 307,341 | 1,633,294 | 1,940,635 | 100.0% |
| 2025-12-08 | 649,662 | 7,026,283 | 7,675,945 | 100.0% |
| 2025-12-01 | 203,742 | 1,259,289 | 1,463,031 | 100.0% |
| 2025-11-24 | 117,425 | 1,230,262 | 1,347,687 | 100.0% |
| 2025-11-17 | 270,425 | 2,218,944 | 2,489,369 | 100.0% |
| 2025-11-10 | 179,198 | 1,977,089 | 2,156,287 | 100.0% |
| 2025-11-03 | 432,710 | 2,372,040 | 2,804,750 | 100.0% |
| 2025-10-27 | 214,036 | 2,867,208 | 3,081,244 | 100.0% |
| 2025-10-20 | 164,508 | 2,846,631 | 3,011,139 | 100.0% |
| 2025-10-13 | 480,485 | 4,086,086 | 4,566,571 | 100.0% |
| 2025-10-06 | 2,036,204 | 34,690,413 | 36,726,617 | 100.0% |
| 2025-09-29 | 950,787 | 3,928,355 | 4,879,142 | 100.0% |
| 2025-09-22 | 869,454 | 6,129,258 | 6,998,712 | 100.0% |
| 2025-09-15 | 4,995,036 | 114,782,776 | 119,777,812 | 100.0% |
| 2025-09-08 | 37,108 | 696,497 | 733,605 | 100.0% |
| 2025-09-01 | 25,222 | 320,407 | 345,629 | 100.0% |
| 2025-08-25 | 122,374 | 417,790 | 540,164 | 100.0% |
| 2025-08-18 | 47,938 | 325,090 | 373,028 | 100.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1671584
CUSIP
03835L702
13F (30d)
10 filings
10 filers
Visit website
Investor relations